Sign up to save your podcasts
Or
Share MACE and SGLT2 Inhibitors: Do They Have an Impact?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
MACE and SGLT2 Inhibitors: Do They Have an Impact?
Guest: Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC
Explore the future of cholesterol management with cutting-edge pharmacologic therapies and the latest research on lipid-lowering treatments. Understand the transformative impact of AI in primary cardiovascular disease prevention, as highlighted by groundbreaking trials like TRANSFORM. Stay informed on how emerging therapies can help patients achieve optimal LDL-C levels and reduce cardiovascular risks.
View all episodes
By ReachMDGuest: Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC
Explore the future of cholesterol management with cutting-edge pharmacologic therapies and the latest research on lipid-lowering treatments. Understand the transformative impact of AI in primary cardiovascular disease prevention, as highlighted by groundbreaking trials like TRANSFORM. Stay informed on how emerging therapies can help patients achieve optimal LDL-C levels and reduce cardiovascular risks.